Mirati Therapeutics Stock Price (NASDAQ:MRTX)

Add to My Stocks
$39.12 $0.64 (1.61%) MRTX stock closing price Dec 07, 2018 (Closing)
Prev Close* : $39.76
Market Cap:
$1.27B
Day Low: $37.73
52 Week Low: $15.35
Open: $39.4
Volume: 432,610
Day High: $40.27
52 Week High: $65.35
Dividend:
0.00

Latest Stock Market News

Latest Articles

Mirati Therapeutics News - From Partners

Last Analytics

hathaway stock price banco santander dividend yield santander share value today dow history chart warren buffett hathaway share price berkshire hathaway a stock quote xom price quote santander share value today indu stock price bank santander share price dow jones pe santander shares price share price santander bank santander banco share price

MRTX Stockcharts

View MRTX PE ratio, PS ratio stocks charts and compare with peers.
Note: Compare Mirati Therapeutics stock price history with the index and industry peers.

Mirati Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Mirati Therapeutics Returns

ROE
(return on equity)
-54%

Mirati Therapeutics Financial Ratios

Asset Turnover
0
Receivables Turnover
-
Debt to Equity
0
Dividend Yield
-999.0000

MRTX Industry Peers

Company Price Change (%)
Orchard Therapt (ORTX)15.090.89 (5.57%)
Sangamo Therap (SGMO)11.310.62 (5.2%)
Affymetrix (AFFX)14.010.02 (0.14%)
Iovance Biothpt (IOVA)8.970.98 (9.85%)
Baxalta (BXLT)46.020.18 (0.39%)
Regeneron Pharma (REGN)372.838.86 (2.32%)
Alexion Pharma (ALXN)115.65.44 (4.49%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Momenta Pharma (MNTA)14.252.17 (17.96%)
Agenus (AGEN)2.630.28 (11.91%)
Intra-Cellular Therapies (ITCI)15.091.56 (11.53%)
Clovis Oncology (CLVS)21.241.37 (6.89%)
Fate Therapeutics (FATE)16.540.8 (5.08%)
Osiris Therapeutics (OSIR)13.540.6 (4.64%)
ANI Pharma (ANIP)53.52.02 (3.92%)
Top gainers from Medical-Biomed-Genetics industry
* As of Dec 07, 2018
CompanyPriceChange (%)
IOVANCE BIOTHPT (IOVA)8.970.98 (9.85%)
Insmed (INSM)15.761.57 (9.06%)
Dicerna Pharma (DRNA)12.741.22 (8.74%)
Ultragenyx Pharma (RARE)46.663.83 (7.59%)
Immunomedics (IMMU)17.571.41 (7.43%)
Alnylam Pharma (ALNY)74.385.35 (6.71%)
Sorrento Therapeutics (SRNE)30.2 (6.25%)
Top losers from Medical-Biomed-Genetics industry
* As of Dec 07, 2018

Mirati Therapeutics, Inc. Stock News - Partner Headlines

Mirati Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-70.42M-83.11M-64.54M-43.69M-52.85M
Total Operating Expense71.53M83.77M64.7M39.1M31.95M
View Mirati Therapeutics income statement
balance sheet20172016201520142013
Total Assets157.24M63.44M128.01M33.47M64.53M
Total Liabilities13.95M15.13M9.84M5.41M38.65M
Shareholders Equity143.28M48.3M118.17M28.06M25.88M
View Mirati Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.98M4.29M3.02M-1.36M-
Net Cash from (used by) Operating Activities-64.7M-68.01M-50.71M-32.74M-29.45M
Increase (Decrease) in Prop Plant And Equipment-0.08M-0.19M-0.32M-0.38M-0.2M
View Mirati Therapeutics cash flow statement

Mirati Therapeutics Stock Message Board

As of last trading day, Mirati Therapeutics stock price was $39.12. Mirati Therapeutics market capitalization is $1.27B and it represents the total market value of MRTX stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Mirati Therapeutics stock analysis.

Demand for a stock decides its stock market price. For example, if more investors want to buy MRTX stock than sell it, then Mirati Therapeutics stock price goes up. Conversely, if more investors wanted to sell MRTX stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Mirati Therapeutics stock quote data shows the number of shares traded. For Ex: 432,610 Mirati Therapeutics shares were traded as of last trading day, as seen from Mirati Therapeutics stock chart. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Mirati Therapeutics does not pay dividends. To check the historical stock price movement, all time high, and all time low of MRTX, view Mirati Therapeutics stock price history.